Eptigrilin 0.75mg/ml Infusion
By Eptigrilin
Rx
100ml Infusion in a Bottle

Composition
Eptifibatide(0.75mg/ml)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
January, 2027

liver
Limited data is accessible regarding the utilization of Eptigrilin 0.75mg/ml Infusion in individuals with liver disease. It is advisable to consult with your healthcare provider before using this infusion. Moreover, it is not recommended to use Eptigrilin 0.75mg/ml Infusion in individuals with severe liver disease.

kidney
Eptigrilin 0.75mg/ml Infusion requires caution in patients with kidney disease. Dose adjustment may be necessary. Not advised for severe kidney disease; consult your doctor before use.

alcohol
It is not known if it is safe to drink alcohol while taking Eptigrilin 0.75mg/ml Infusion. Please ask your doctor for advice.

driving
It is better to consult your doctor. Refrain from driving if you have symptoms impairing focus and reaction time when using Eptigrilin 0.75mg/ml Infusion.

pregnancy
Eptigrilin 0.75mg/ml Infusion is generally safe during pregnancy, with animal studies showing minimal impact on the baby. Limited human studies available, so consulting a doctor is recommended for more information.

breastfeeding
During breastfeeding, caution should be taken when using Eptigrilin 0.75mg/ml Infusion. It is advised to pause breastfeeding until the mother's treatment is finished and the drug is cleared from her system.
| Habit Forming | No |
| Chemical Class | Amino Acids, Peptides, and Analogues |
| Therapeutic Class | - |
| Action Class | Glycoprotein IIb/IIIa inhibitors |
₹7516.55
₹8843
15% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024
